Laptm4A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| LAPTM4A - Lysosomal Associated Transmembrane Protein 4 Alpha | |
|---|---|
| Gene Symbol | LAPTM4A |
| Full Name | Lysosomal Associated Transmembrane Protein 4 Alpha |
| Chromosomal Location | 2p23.3 |
| NCBI Gene ID | 9515 |
| Ensembl ID | ENSG00000137714 |
| UniProt ID | Q9Y3Q5 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cancer |
| Protein | LAPTM4A Protein |
LAPTM4A (Lysosomal Associated Transmembrane Protein 4 Alpha) is a member of the LAPTM family of proteins involved in lysosomal function, autophagy regulation, and cellular homeostasis. Like other LAPTM proteins, LAPTM4A localizes to lysosomes and participates in membrane trafficking, protein quality control, and stress responses. It is expressed in various tissues including the brain, where it supports neuronal survival and function.
The LAPTM4A gene is located on chromosome 2p23.3 and encodes a protein of approximately 224 amino acids. The gene contains multiple exons and undergoes alternative splicing in some tissues.
LAPTM4A functions as a membrane protein supporting lysosomal trafficking:
LAPTM4A participates in autophagy pathway regulation:
The protein is involved in cellular stress responses:
LAPTM4A shows widespread expression:
LAPTM4A is implicated in Alzheimer's disease pathogenesis:
Autophagy impairment: Altered LAPTM4A expression contributes to defective autophagy in AD brains[1]
Lysosomal dysfunction: Contributes to lysosomal membrane permeabilization observed in AD
Amyloid metabolism: May affect amyloid precursor protein processing
In Parkinson's disease, LAPTM4A plays protective roles:
Alpha-synuclein clearance: Supports autophagy-mediated degradation of alpha-synuclein aggregates
Mitochondrial quality control: Contributes to mitophagy regulation in dopaminergic neurons
Neuroprotection: May protect neurons from oxidative stress and mitochondrial dysfunction
LAPTM4A is also dysregulated in various cancers:
The study of Laptm4A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.